Miniziston

Roman name

Minisiston

The composition and the form of

1 tablet contains levonorgestrel 125 µ g and etinilestradiola 30 µ g; blistere in 21 pcs. , in the box one blister.

Indications

Contraception, the functional disorders of menstruation, dismenorea.

Pregnancy and lactation

Contraindicated in pregnancy.

Contraindications

Hypersensitivity, pregnancy, gormonozawisimae tumours of the mammary glands and uterus expressed violations functions and liver cancer, diabetes mellitus with circulatory complications embolic disease (incl. disease), brain arteries and veins, arterial hypertension (severe).

Side-Effects

In rare cases, headache, depression, nausea, diarrhoea, pain mammary glands; In the long-term employment, it is very rarely hloazma, deteriorating portable contact lenses.

Precautions

Be wary appoint patients varikoznam expansion veins, flebitom, with multiple sclerosis, epilepsy, endometriosis, liver diseases. Admission should stop and see a doctor when the first migrenozopodobnykh headaches, severe violations of when the pregnancy, acute trombose, depression or kidney jelthe greatly increase AD.

Dosing and Administration

Inside. For contraception, for one tablet a day (the interval between regular doses should not exceed 36 hours) within 21 days, then break room and the new Zikl.pri functional unit selects a doctor.

Storage conditions

List B. Under normal circumstances,

Shelf life

5 years

The registration

011490/01-1999

Directory → Hormones and their antagonists → Estrogens, gestagena; Their homologues and antagonists → Miniziston